It's All About/Juvenile Diabetes Research Foundation/Minneapolis/Curing Type 1 Diabetes
Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF prioritizes its funding for type 1 diabetes research in four interrelated therapeutic areas: autoimmune therapies, β-cell therapies, prevention of complications, and glucose control. Each therapeutic area encompasses a diverse portfolio of research programs that span from exploratory to preclinical proof-of-principle and on to clinical proof-of-concept research. The organization’s overarching strategy focuses on addressing critical gaps and challenges, catalyzing innovative and transformational research, advancing and translating research, creating collaborations, and accelerating time lines at all stages of research development. To facilitate downstream partnering and follow-on funding, JDRF increasingly supports product development by “de-risking” projects, thereby decreasing the barriers of entry for future funders. Living with T1D is a constant balancing act. People with T1D must regularly monitor their blood-sugar level, inject or continually infuse insulin through a pump, and carefully balance their insulin doses with eating and daily activities throughout the day and night.
T1D is a serious and stressful disease to manage. Treatment options are improving all the time, and people with T1D are able to lead normal, productive and inspiring lives. JDRF is driving research to improve the technology people with T1D use to monitor blood-sugar levels and deliver the proper doses of insulin, as well as research that will ultimately deliver a cure. But even with intensive disease management, a significant portion of their day is still spent with high or low blood-sugar levels, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, kidney disease and amputation. Visitors might want to launch their sightseeing venture with an overview of the city from the observation deck atop the Foshay Tower and catch a glimpse of the Farmers’ Market along the Nicollet Mall. The Minneapolis Planetarium is a popular site, as is Underwater World, a 4.5 million-liter (1.2 million-gallon), walk-through aquarium at the Mall of America. The Minnesota Zoo hosts 450 species of animals featured in their natural habitats. For a thrill, visitors can take a ride on the Wild Thing “hyper coaster” at Valleyfair! Family Amusement Park. For a tamer afternoon, there are an abundance of museums in Minneapolis. While many display fine art and history, several host unique exhibits, from medical quackery to children’s interactive games. Gray Line sightseeing tours of the Twin Cities area visit Nicollet Mall and other attractions like: Ard Godfrey House, Good Sports Bar and Grill, IDS Building, St. List of Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/41420 JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It is important to note the main points –
Incretin-Based Therapies,Promise Gala,blindness,CRFD mortality,ACCORD Trial,GDM,Lee Ducat,CONCEPTT,Rapid Insulin,Insulin Pump Therapy,Medical Research Council,Type 2 Diabetes,Diabetes Complications,Bag of Hope,cholesterol levels,ADVANCE Trial,hypoglycemic episodes,triglyceride,fundraise,A1C Test,Oral Glucose Tolerance Test,fasting lipid profile,insulin dependent diabetes,Mill City,transplantation insulin-secreting cells,Curing T1D,low-density lipoprotein cholesterol,Estrogen in Type 1 Diabetes,glyburide,Pancreas,insulin receptors,Type 1 Diabetes Dictionary,Kidney Disease,blood glucose meter,Beta Cell Health and Survival,Murderapolis,NIDDM,Clinical Trials,high blood glucose,eAG,insulin analogues,implantable insulin pump,Medical Device,JDRF,insulin strength,insulin.